首页> 外国专利> METHOD OF COMPLEX TREATMENT AND PREVENTION OF RECURRENCES OF MUSCULAR-NON-INVASIVE FORMS OF URINARY BLADDER CANCER

METHOD OF COMPLEX TREATMENT AND PREVENTION OF RECURRENCES OF MUSCULAR-NON-INVASIVE FORMS OF URINARY BLADDER CANCER

机译:膀胱膀胱癌无创性的复杂治疗方法和预防复发

摘要

FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to oncology and oncological surgery, and can be used for complex endourethral treatment and prevention of recurrences of muscular non-invasive forms of urinary bladder cancer. For this purpose bilpolar transurethral resection of urinary bladder tumour in physiological solution is performed. After that, on 25-30 day once per week carried out is 1.5-2 month long induction course of intravesical immunotherapy with medicinal composition, which is prepared immediately before introduction into urinary bladder by mechanical mixing of 100-120 mg of BCG Imuron vaccine and 10 g of Tizol gel in 50 g of physiological solution. Time of exposure of medicinal composition in urinary bladder constitutes 30 minutes. 1 month after break in case of absence of tumour recurrence and satisfactory tolerance of treatment first course of supporting intravesical therapy with said medicinal composition is carried out once monthly with 12 month duration. When first course is completed, 1-month break is made. In case of absence of tumour recurrence and satisfactory tolerance of treatment second course of supporting intravesical therapy is carried out once monthly with 12 month duration.EFFECT: method provides increase of recurrence-free period duration and improvement of patients' life quality with reduction of treatment toxicity and reduction of complications of performed drug therapy.2 dwg, 5 tbl, 2 ex
机译:技术领域本发明涉及医学,即涉及肿瘤学和肿瘤外科手术,并且可以用于复杂的神经内膜治疗和预防肌肉非侵入性形式的膀胱癌的复发。为了这个目的,在生理溶液中进行膀胱肿瘤的双极经尿道切除术。此后,在每周25-30天进行一次1.5-2个月长的药物组合物膀胱内免疫疗法诱导过程,该过程是在将100-120 mg BCG Imuron疫苗和200-120 mg BCG机械混合后立即引入膀胱制备的。在50 g生理溶液中加入10 g Tizol凝胶。药物组合物在膀胱中的暴露时间为30分钟。如果没有肿瘤复发和令人满意的治疗耐受性,则在休息后1个月,用所述药物组合物进行膀胱内治疗的第一疗程每月进行一次,持续时间为12个月。第一门课程完成后,将休息1个月。如果没有肿瘤复发且对治疗的耐受性令人满意,则每月进行一次第二次膀胱内支持治疗,疗程为12个月。效果:该方法可增加无复发时间,并通过减少治疗来改善患者的生活质量药物治疗的毒性和并发症减少2 dwg,5 tbl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号